Durvalumab + Gemcitabine/Cisplatin
Treatment used for 1 condition
Total Trials
5
Total Participants
10K
Avg Effectiveness
60%
Avg Safety Score
28%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.